Name: NEUROONE MEDICAL TECHNOLOGIE (NMTC) Stock
Brand: NEUROONE MEDICAL TECHNOLOGIE
Rating: 4 (3 reviews)

NMTC Latest News, Press Relases and Analysis

All

Press Releases

4 months ago - By: The Motley Fool

NeuroOne Revenue Jumps 105 Percent in Q3

3 months ago - By: NeuroOne Medical Technologies Corporation

NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025

4 months ago - By: Zacks Investment Research - Mentions: BSX WST MEDP

NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment

4 months ago - By: NeuroOne Medical Technologies Corporation

NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

4 months ago - By: The Motley Fool

NeuroOne Q3 Revenue Jumps 105 Percent

4 months ago - By: NeuroOne Medical Technologies Corporation

NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%

4 months ago - By: NeuroOne Medical Technologies Corporation

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

4 months ago - By: Benzinga - Mentions: BTCM DE TIC DFLI ...

Earnings Scheduled For August 14, 2025

4 months ago - By: NeuroOne Medical Technologies Corporation

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

5 months ago - By: Benzinga - Mentions: PBM IRIX TTNP HCTI ...

12 Health Care Stocks Moving In Thursday's After-Market Session

5 months ago - By: NeuroOne Medical Technologies Corporation

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

6 months ago - By: NeuroOne Medical Technologies Corporation

NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

6 months ago - By: NeuroOne Medical Technologies Corporation

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

6 months ago - By: NeuroOne Medical Technologies Corporation

NeuroOne to Attend MedInvest’s MedTech, AI & Digital Health Conference on June 3-4, 2025

7 months ago - By: NeuroOne Medical Technologies Corporation

NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%

7 months ago - By: NeuroOne Medical Technologies Corporation

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor

7 months ago - By: NeuroOne Medical Technologies Corporation

NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time

8 months ago - By: NeuroOne Medical Technologies Corporation

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

8 months ago - By: NeuroOne Medical Technologies Corporation

NeuroOne® Issues Letter to Shareholders

8 months ago - By: NeuroOne Medical Technologies Corporation

NEUROONE MEDICAL TECHNOLOGIE (NMTC) Stock News

NMTC Latest News, Press Relases and Analysis

NeuroOne Revenue Jumps 105 Percent in Q3

NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025

NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment

NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne Q3 Revenue Jumps 105 Percent

NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

Earnings Scheduled For August 14, 2025

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

12 Health Care Stocks Moving In Thursday's After-Market Session

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

NeuroOne to Attend MedInvest’s MedTech, AI & Digital Health Conference on June 3-4, 2025

NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor

NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne® Issues Letter to Shareholders

NeuroOne® OneRF® Technology Success Story Featured on Fox News